Recruiting Xeroderma Pigmentosum Studies in Chicago
About Xeroderma Pigmentosum Clinical Trials in Chicago
Xeroderma pigmentosum is a rare genetic disorder characterized by extreme sensitivity to ultraviolet light, leading to very high risk of skin cancer and eye damage. It is caused by defects in DNA repair mechanisms. Management requires strict UV protection and vigilant cancer surveillance.
There are currently 1 xeroderma pigmentosum clinical trials recruiting participants in Chicago, IL. These studies are seeking a combined 2,076 participants. Research is being sponsored by Guerbet. Clinical trial participation is free and participants receive study-related medical care at no cost.
Xeroderma Pigmentosum Clinical Trials in Chicago — FAQ
Are there xeroderma pigmentosum clinical trials in Chicago?
Yes, there are 1 xeroderma pigmentosum clinical trials currently recruiting in Chicago, IL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chicago?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.
Are clinical trials in Chicago free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.
What xeroderma pigmentosum treatments are being tested?
The 1 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for xeroderma pigmentosum.
Data updated March 2, 2026 from ClinicalTrials.gov